Results 101 to 110 of about 3,203 (180)

Vitamin D: are all compounds equal? [PDF]

Clin Kidney J
Magagnoli L, Cassia M, Galassi A, Ciceri P, Massó E, Gelpi R, Bover J, Cozzolino M.   +7 more
europepmc   +1 more source

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer. [PDF]

Cancer Gene Ther
Bandi DSR, Sarvesh S, Foote J, Welsch D, Cheng C, Akce M, Nagaraju GP, El-Rayes BF, El-Rayes BF.   +8 more
europepmc   +1 more source

Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma. [PDF]

Ther Adv Med Oncol
Powell J, Viniotis AF, Irwin C, Jameson GS, Caldwell L, Borazanci EH.   +5 more
europepmc   +1 more source

Targeted therapeutics for pancreatitis. [PDF]

Front Physiol
Alsaleh T, George J.
europepmc   +1 more source

Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study. [PDF]

BMC Nephrol
Checa-Ros A, Locascio A, Okojie OJ, Abellán-Galiana P, D'Marco L.   +4 more
europepmc   +1 more source

New drugs: Paricalcitol

Australian Prescriber, 2008
openaire   +1 more source

Fibromyalgia, quality of life, and thiol/disulfide homeostasis in patients undergoing hemodialysis: A multicenter cross-sectional study. [PDF]

Medicine (Baltimore)
Ağir H, Çifçi A, Kültür T, Öztürk H, Felek D, Haciömeroğlu A, Varlibaş A, Neşelioğlu S, Erel Ö.   +8 more
europepmc   +1 more source

Identification of drug-related cardiovascular risks: A comprehensive analysis using the FAERS database (2004-2024). [PDF]

PLoS One
Qin N, Gan Y, Ouyang J, Qin J, Tang Y, Wu H, Wei S, Wang H, Huang J.   +8 more
europepmc   +1 more source

Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction. [PDF]

Oncologist
Chung V, Alistar A, Becerra C, Kasi A, Borazanci E, Jameson GS, Roe DJ, Wertheim BC, Cridebring D, Truitt M, Downes M, Barrett MT, Korn R, Lee K, Han H, Evans R, Von Hoff DD.   +16 more
europepmc   +1 more source

Impact of a Single Hemodialysis Session on Oxidative Stress-Inducing and Oxidative Damage Biomarkers in End-Stage Kidney Disease Patients. [PDF]

Curr Issues Mol Biol
Varemmenou A, Michail E, Kalaitzopoulou E, Papadea P, Skipitari M, Papasotiriou M, Papachristou E, Goumenos D, Georgiou CD.   +8 more
europepmc   +1 more source